Selected Antimicrobial Information – Companion Animal

Clindamycin [Companion]

Restriction Status

Unrestricted

Dose

Species Usage Dose
Cats



Label dose 11-33mg/kg PO q24h for no more than 14d
For skin or soft tissue infections 11-33mg/kg PO or SQ q24h for 7-28d or 5-11mg/kg PO or SQ q12h for 7-28d (extra-label use)
For sepsis
10-15mg/kg IV q12h (extra-label use)
For toxoplasmosis 10-15mg/kg PO or IV q12h
For dental prophylaxis/post-dental procedures 5-10mg/kg PO q12h for 5-8d (extra-label use)
Most commonly used dose range 10-15mg/kg PO or IV q12h
Dogs


Label dose 5.5-33mg/kg PO q12h for no more than 28d
For staphylococcal pyoderma 11mg/kg PO or SQ q24h or 5.5mg/kg PO q12h to resolution of clinical signs or one week past resolution (extra-label use)
For staphylococcal osteomyelitis 11mg/kg PO q12h for 28-42d (q8h for anaerobic osteomyelitis) (extra-label use)
For other wounds or abscesses, or dental infections
11-33mg/kg PO, SQ, or IV q12h for 7-28d (extra-label use)
For dental prophylaxis/post-dental procedures 5-10mg/kg PO q12h for 5-8d (extra-label use)
For sepsis 10-15mg/kg IV q12h (extra-label use)
For toxoplasmosis 10-15mg/kg PO or IV q12h
Most commonly used dose range 10-15mg/kg PO or IV q12h

Brand Name(s)

Antirobe®, Cleoncin®

Background

Clindamycin is a bacteriostatic, time-dependent lincosamide antibiotic with good activity against Gram-positive organisms such as Staphylococcus spp., and many anaerobes. It is not effective against most Gram-negative aerobes including Enterobacteriaceae and Pseudomonas aeruginosa, and Enterococcus spp. are also intrinsically resistant. Distribution is wide, including into bone and across inflamed meninges. Both unchanged drug and metabolites are excreted in urine, feces, and bile.

Acceptable Uses

  • Treatment of staphylococcal pyoderma. Acceptable as an empiric treatment.
  • Treatment of other skin infections including abscesses and wounds, including those with an anaerobic component (e.g. cat bite abscess).
  • Treatment of dental infections or as dental prophylaxis. Most efficacious when used with mechanical dental cleaning.
  • Treatment of staphylococcal or anaerobic osteomyelitis.
  • In combination with an antimicrobial with Gram-negative coverage, empiric treatment of sepsis or bacteremia.
  • First choice of treatment for toxoplasmosis in dogs and cats.

Unacceptable Uses

  • Treatment of suspected or culture-confirmed Gram-negative infections.
    • D-test (disk diffusion method using Clindamycin and Erythromycin disks) used to detect inducible Clindamycin resistance in Staphylococcus species.

Formulations Available within the OSU Pharmacy

  • Clindamycin 25mg capsule
  • Clindamycin 75mg capsule
  • Clindamycin 150mg capsule
  • Clindamycin 300mg capsule
  • Clindamycin 25mg/ml oral suspension
  • Clindamycin 150mg/ml injectable suspension

Notes

  • N/A

License

Icon for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

OSU VMC Antimicrobial Use Guidelines Copyright © 2018 by The Ohio State University College of Veterinary Medicine is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, except where otherwise noted.